tirzepatide and alcohol reduction reduces drinking relapse-like behaviours in rodents Tirzepatide attenuates dopamine reward signaling

Tirzepatide works with GLP-1 and GIP, making it a dual-pathway agonist

Tirzepatide is a medication, made by Eli Lilly, that treats diabetes, obesity, and sleep apnea

Whether you are managing anxiety symptoms, optimizing your titration schedule, or simply seeking trustworthy information about peptides and mental health, SeekPeptides provides the support and science you need

Vol Endocrinology

During follow-up of interventions that induce weight reduction, it has been difficult to determine whether a concurrent reduction of, e.g., visceral fat was in line with the amount of weight lost, or if there was larger reduction than expected